Yasu Takeuchi

Toranomon, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Serum microRNA-122 Is Associated with the Therapeutic Response to Diet and Exercise Therapy in Patients with Steatotic Liver Disease.

Serum microRNA-122 Is Associated with the Therapeutic Response to Diet and Exercise Therapy in Patients with Steatotic Liver Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: May 06, 2026

Serum MicroRNA-122 Predicts Early Progressive Disease in Unresectable Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Therapy.

Serum MicroRNA-122 Predicts Early Progressive Disease in Unresectable Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Therapy.

Journal: Oncology

Published: January 22, 2026

Modeling of hepatitis B virus infection spread in primary human hepatocytes.

Modeling of hepatitis B virus infection spread in primary human hepatocytes.

Journal: Journal of virology

Published: August 04, 2025

Modeling of hepatitis B virus infection spread in primary human hepatocytes.

Modeling of hepatitis B virus infection spread in primary human hepatocytes.

Journal: bioRxiv : the preprint server for biology

Published: February 20, 2025

Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan.

Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 24, 2024

Insights into product and process related challenges of lentiviral vector bioprocessing.

Insights into product and process related challenges of lentiviral vector bioprocessing.

Journal: Biotechnology and bioengineering

Published: April 07, 2023

Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.

Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.

Journal: Nature

Published: March 25, 2022

Nationwide awareness-raising program for viral hepatitis in Japan: the "Shitte kan-en" project.

Nationwide awareness-raising program for viral hepatitis in Japan: the "Shitte kan-en" project.

Journal: Global health & medicine

Published: May 31, 2021

Evolution of enhanced innate immune evasion by SARS-CoV-2.

Evolution of enhanced innate immune evasion by SARS-CoV-2.

Journal: Nature

Published: May 31, 2021

Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.

Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.

Journal: Biomolecules

Published: January 27, 2021

Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.

Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.

Journal: The Journal of infectious diseases

Published: April 03, 2020

A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.

A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.

Journal: Clinical journal of gastroenterology

Published: August 14, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026